HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adrenocortical degeneration in dogs, monkeys, and rats treated with alpha-(1,4-dioxido-3-methylquinoxalin-2-YL)-N-methylnitrone.

Abstract
The antibacterial compound alpha-(1,4-dioxido-3-methylquinoxalin-2-yl)-N-methylnitrone (DMNM), which was administered for a maximum period of 90 days, was given orally at 0, 7.5, 15.0 or 22.5 mg/kg/day for dogs; 0, 15, 50 or 100 mg/kg/day for rats; and 35 mg/kg/day for monkeys. Reduced food consumption and weight gain, depression, debility, and deaths occurred starting at doses (mg/kg/day) of 15 in dogs, 35 in monkeys and 50 in rats. Frequent emesis and occasional black, tarry feces were also observed in most treated dogs. Necropsy examinations revealed small, pale adrenal glands in rats given a dose of 50 mg/kg/day and gastrointestinal hemorrhage in dogs administered 15.0 or 22.5 mg/kg/day of DMNM. Microscopically, vacuolar degeneration of the canine, monkey and rat adrenal cortex was seen at all dosages and appeared to progress from the zona reticularis to the zona glomerulosa. In rats treated with 50 mg/kg/day of the drug chronic lesions of adrenal cortical fibrosis, atrophy, and nodular hyperplasia were also detected. The only other significant microscopic lesions consisted of mild testicular atrophy and occasional gastric erosions in dogs treated with 7.5 mg/kg/day of DMNM.
AuthorsJ T Yarrington, K W Huffman, J P Gibson
JournalToxicology letters (Toxicol Lett) 1981 Jun-Jul Vol. 8 Issue 4-5 Pg. 229-34 ISSN: 0378-4274 [Print] Netherlands
PMID7268807 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adrenal Glands (cytology)
  • Animals
  • Anti-Bacterial Agents (toxicity)
  • Dogs
  • Dose-Response Relationship, Drug
  • Female
  • Macaca mulatta (anatomy & histology)
  • Male
  • Rats
  • Species Specificity
  • Stomach (cytology)
  • Testis (cytology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: